Improving cholesterol management after heart events through education

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This implementation trial aims to determine if educating healthcare providers and patients about cholesterol management can prevent future heart problems in individuals hospitalized for a cardiac event. The study will assess whether training doctors improves the frequency of cholesterol checks and if a 'care champion' can assist discharged patients in achieving their cholesterol goals. Participants will complete two brief surveys over the phone, one at enrollment and another six months later, to evaluate the effectiveness of the intervention. Data will be collected from electronic health records and patient-reported outcomes to measure success.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age ≥ 18 years old
2. Admitted with Type 1 NSTEMI or STEMI, and/or percutaneous coronary revascularization
3. LDL-C level during admission ≥ 70 mg/dL
4. Primary care clinician and/or cardiologist within the health system (and with access to the same EHR) who will manage the patient in the outpatient setting

Exclusion Criteria:

1. Determined to be highly unlikely to survive and/or to continue follow-up in that health system for at least 6 months (including those on hospice or with significant dementia), as identified by site investigator
2. Underwent CABG (would therefore be discharged from surgical service)

Where it's running

• Allina Health
  Minneapolis, Minnesota, United States Recruiting

Study contacts

• Study coordinator: Neha Pagidipati, MD
• Email: neha.pagidipati@duke.edu
• Phone: 919 668 8742

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Corrie Lipids program to help lower high LDL cholesterol

  This program tests whether a smartphone app combined with clinician education and coaching can help adults with uncontrolled LDL-C and high cardiovascular risk reach their cholesterol goals.

  Recruiting Johns Hopkins University · Baltimore, Maryland · NCT07478887

• ABP-745 to reduce atherosclerotic plaque in people with ASCVD

  This trial will test whether ABP-745 reduces atherosclerotic plaque over 52 weeks in adults (18–75) with ASCVD who are already taking oral lipid-lowering therapy.

  Recruiting Phase 2 Atom Therapeutics Co., Ltd · Beverly Hills, California and 32 other locations · NCT07303777

• Long-term remote ischemic conditioning to protect the heart, brain, and kidneys in very-high-risk ASCVD

  We will try regular remote ischemic conditioning to see if it protects the heart, brain, and kidneys in adults over 40 with very-high-risk ASCVD.

  Recruiting General Hospital of Shenyang Military Region · Shenyang · NCT07270887

• Comparing two cholesterol-lowering treatments for diabetes risk in heart disease patients

  This study is testing whether a combination of two cholesterol-lowering medications can help heart disease patients with prediabetes avoid developing diabetes better than a stronger single medication.

  Recruiting Phase 4 Korea University Anam Hospital · Seoul · NCT06767774

• Blocking IL-1β to reduce artery inflammation in people with coronary artery disease, including those with TET2 clonal hematopoiesis

  This trial will see if canakinumab, a drug that blocks IL‑1β, reduces artery inflammation in adults with prior heart attack or coronary stents, some of whom have TET2 clonal hematopoiesis.

  Recruiting Phase 2 Massachusetts General Hospital · Boston, Massachusetts · NCT06691217

• Evaluating HST101 for lowering cholesterol in Chinese patients

  This study is testing if a new drug called HST101 can lower cholesterol levels in Chinese patients who have high cholesterol and are at risk for heart disease.

  Recruiting at 17 sites Phase 3 Hasten Biopharmaceutical Co., Ltd. · Beijing, Beijing Municipality and 17 other locations · NCT06568471

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.